SCHEMBL12759589

SCHEMBL12759589

COc1cn2c3ccccc3c3ccccc3c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
ADORA2A P29274 3/20 0.35
GPR3 P46089 1/20 0.35
TSHR P16473 2/20 0.35
BRD9 Q9H8M2 1/20 0.35
BRD7 Q9NPI1 1/20 0.35
USP2 O75604 1/20 0.35
GLA P06280 1/20 0.35
ALOX12 P18054 1/20 0.35
CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12759643 0.84 GPR3 (0.33) DDB1CRBNALDH1A1HSD17B10L3MBTL1
SCHEMBL861330 0.77 HSD17B10 (0.47) ALDH1A1HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL16328883 0.74 KDM4E (0.35) ALDH1A1HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL12759590 0.73 MAPT (0.39) ALDH1A1HSD17B10MEN1KMT2AL3MBTL1
SCHEMBL12759587 0.73 MAPT (0.37) ALDH1A1HSD17B10MEN1KMT2AL3MBTL1
SCHEMBL13325840 0.71 ADORA2A (0.53) ALDH1A1HSD17B10MEN1KMT2AL3MBTL1
SCHEMBL12759626 0.70 L3MBTL1 (0.37) ALDH1A1MEN1KMT2AL3MBTL1KDM4E
SCHEMBL3356083 0.69 ADORA2A (0.46) ALDH1A1MEN1KMT2AL3MBTL1KDM4E
SCHEMBL13309569 0.68 CYP1A2 (0.38) ALDH1A1HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL29929754 0.68 ADORA2A (0.35) DDB1CRBNALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE ZFR, PORCN, OR10J3 DDB1 2224/4885CRBN 2461/4885ALDH1A1 2296/4885
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device ZFR, PORCN, OR10J3 DDB1 2224/4885CRBN 2461/4885ALDH1A1 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.